Financial Architects (New Jersey)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $455K | Sell |
7,122
-857
| -11% | -$57.5K | 0.07% | 217 |
|
|
2023
Q1 | $553K | Sell |
7,979
-226
| -3% | -$15.9K | 0.09% | 193 |
|
|
2022
Q4 | $590K | Sell |
8,205
-1,056
| -11% | -$79.6K | 0.1% | 189 |
|
|
2022
Q3 | $658K | Buy |
9,261
+1,489
| +19% | +$108K | 0.11% | 168 |
|
|
2022
Q2 | $598K | Buy |
7,772
+119
| +2% | +$9.06K | 0.76% | 27 |
|
|
2022
Q1 | $559K | Sell |
7,653
-91
| -1% | -$6.11K | 0.08% | 194 |
|
|
2021
Q4 | $483K | Sell |
7,744
-95
| -1% | -$5.57K | 0.07% | 207 |
|
|
2021
Q3 | $464K | Buy |
7,839
+8
| +0.1% | +$527 | 0.07% | 209 |
|
|
2021
Q2 | $523K | Buy |
7,831
+109
| +1% | +$7.11K | 0.08% | 193 |
|
|
2021
Q1 | $488K | Sell |
7,722
-440
| -5% | -$27.4K | 0.08% | 195 |
|
|
2020
Q4 | $506K | Buy |
8,162
+8
| +0.1% | +$492 | 0.09% | 168 |
|
|
2020
Q3 | $492K | Sell |
8,154
-68
| -0.8% | -$4.09K | 0.11% | 151 |
|
|
2020
Q2 | $483K | Buy |
8,222
+450
| +6% | +$26.9K | 0.11% | 143 |
|
|
2020
Q1 | $433K | Sell |
7,772
-134
| -2% | -$8.19K | 0.12% | 140 |
|
|
2019
Q4 | $507K | Buy |
7,906
+937
| +13% | +$53.7K | 0.11% | 145 |
|
|
2019
Q3 | $353K | Sell |
6,969
-79
| -1% | -$3.71K | 0.08% | 170 |
|
|
2019
Q2 | $320K | Sell |
7,048
-5,619
| -44% | -$262K | 0.06% | 194 |
|
|
2019
Q1 | $604K | Buy |
12,667
+2,260
| +22% | +$113K | 0.1% | 141 |
|
|
2018
Q4 | $541K | Buy |
10,407
+170
| +2% | +$9.13K | 0.1% | 139 |
|
|
2018
Q3 | $636K | Sell |
10,237
-1,859
| -15% | -$110K | 0.1% | 146 |
|
|
2018
Q2 | $669K | Buy |
12,096
+695
| +6% | +$37.5K | 0.12% | 130 |
|
|
2018
Q1 | $721K | Sell |
11,401
-2,189
| -16% | -$141K | 0.14% | 113 |
|
|
2017
Q4 | $833K | Sell |
13,590
-4,670
| -26% | -$292K | 0.14% | 117 |
|
|
2017
Q3 | $1.16M | Sell |
18,260
-1,224
| -6% | -$71.5K | 0.21% | 90 |
|
|
2017
Q2 | $1.09M | Sell |
19,484
-55
| -0.3% | -$2.99K | 0.19% | 96 |
|
|
2017
Q1 | $1.06M | Sell |
19,539
-656
| -3% | -$36K | 0.19% | 98 |
|
|
2016
Q4 | $1.18M | Buy |
20,195
+3,307
| +20% | +$181K | 0.28% | 76 |
|
|
2016
Q3 | $911K | Buy |
16,888
+1,721
| +11% | +$111K | 0.24% | 81 |
|
|
2016
Q2 | $1.12M | Buy |
15,167
+638
| +4% | +$45.1K | 0.31% | 73 |
|
|
2016
Q1 | $928K | Sell |
14,529
-303
| -2% | -$19.1K | 0.33% | 69 |
|
|
2015
Q4 | $1.02M | Buy |
14,832
+112
| +0.8% | +$7.4K | 0.41% | 59 |
|
|
2015
Q3 | $871K | Buy |
14,720
+175
| +1% | +$11.1K | 0.37% | 63 |
|
|
2015
Q2 | $968K | Sell |
14,545
-462
| -3% | -$30.4K | 0.35% | 61 |
|
|
2015
Q1 | $968K | Buy |
15,007
+432
| +3% | +$27K | 0.38% | 57 |
|
|
2014
Q4 | $860K | Buy |
14,575
+2,691
| +23% | +$152K | 0.38% | 58 |
|
|
2014
Q3 | $608K | Sell |
11,884
-65
| -0.5% | -$3.25K | 0.3% | 75 |
|
|
2014
Q2 | $580K | Buy |
11,949
+77
| +0.6% | +$3.79K | 0.28% | 81 |
|
|
2014
Q1 | $617K | Sell |
11,872
-50
| -0.4% | -$2.66K | 0.37% | 68 |
|
|
2013
Q4 | $634K | Buy |
11,922
+2,713
| +29% | +$138K | 0.37% | 68 |
|
|
2013
Q3 | $431K | Sell |
9,209
-1,839
| -17% | -$80.7K | 0.28% | 78 |
|
|
2013
Q2 | $494K | Buy |
+11,048
| New | +$480K | 0.36% | 62 |
|
Other funds holding BMY
Financial Architects (New Jersey)'s BMY Position: Q2 2023 in Review
Financial Architects (New Jersey) reduced its Bristol-Myers Squibb (BMY) stake by 11% in Q2 2023, selling an estimated $57.5K and leaving 7,122 shares worth $455K. The position accounts for 0.07% of the portfolio, ranked #217.
Financial Architects (New Jersey) first reported a position in BMY in Q2 2013 and has held it in 41 quarters since. The position peaked at $1.18M in Q4 2016. 2,481 funds tracked by Wall St. Rank hold BMY as of Q2 2023.
- Financial Architects (New Jersey) held 7,122 shares of Bristol-Myers Squibb worth $455K as of Q2 2023.
- Financial Architects (New Jersey) sold 857 Bristol-Myers Squibb shares in Q2 2023, an estimated $57.5K.
- Bristol-Myers Squibb made up 0.07% of Financial Architects (New Jersey)'s portfolio in Q2 2023, its #217 holding.
- Financial Architects (New Jersey) first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 41 quarters since.
- Financial Architects (New Jersey)'s Bristol-Myers Squibb position peaked at $1.18M in Q4 2016.
- 2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.
Based on Financial Architects (New Jersey)'s 13F filing for Q2 2023, filed 10 Aug 2023.